Skip to main navigation
  • R&D
    • Research
    • Novel Proprietary Systems
    • Science Communications
  • Therapeutic Approach
  • About Us
  • Careers
  • Investors
  • LinkedIn
  • Terms of Service
  • Privacy Policy
  • Careers
Contact

info@metagenomi.co

 

© 2026 Metagenomi Therapeutics, Inc.

HERO

SEC Filing Details

Investor Menu

Investor Relations

  • Most Recent Information
  • News & Events
    • News Releases
    • Events
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • Annual Reports
    • SEC Filings
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Document Details

Form
10-K
Filing Date
Mar 5, 2026
Document Date
Dec 31, 2025
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Metagenomi Therapeutics, Inc.
Issuer
METAGENOMI THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Headquarters
5959 Horton St, Floor 7
Emeryville, California 94608

Other Locations

1545 Park Avenue
Emeryville, California 94608

1485 Park Avenue
Emeryville, California 94608

Contact

info@metagenomi.co

 
  • LinkedIn
  • Terms of Service
  • Privacy Policy
  • Careers

© 2026 Metagenomi Therapeutics, Inc.

© 2026 Metagenomi Therapeutics, Inc.